These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8389614)
1. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Hunger SP; Tkachuk DC; Amylon MD; Link MP; Carroll AJ; Welborn JL; Willman CL; Cleary ML Blood; 1993 Jun; 81(12):3197-203. PubMed ID: 8389614 [TBL] [Abstract][Full Text] [Related]
2. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. Morrissey J; Tkachuk DC; Milatovich A; Francke U; Link M; Cleary ML Blood; 1993 Mar; 81(5):1124-31. PubMed ID: 8443374 [TBL] [Abstract][Full Text] [Related]
3. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657 [TBL] [Abstract][Full Text] [Related]
4. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707 [TBL] [Abstract][Full Text] [Related]
6. The FEL (AF-4) protein donates transcriptional activation sequences to Hrx-Fel fusion proteins in leukemias containing T(4;11)(Q21;Q23) chromosomal translocations. Morrissey JJ; Raney S; Cleary ML Leuk Res; 1997 Oct; 21(10):911-7. PubMed ID: 9403001 [TBL] [Abstract][Full Text] [Related]
7. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. Butler LH; Slany R; Cui X; Cleary ML; Mason DY Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043 [TBL] [Abstract][Full Text] [Related]
8. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152 [TBL] [Abstract][Full Text] [Related]
9. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. Thirman MJ; Gill HJ; Burnett RC; Mbangkollo D; McCabe NR; Kobayashi H; Ziemin-van der Poel S; Kaneko Y; Morgan R; Sandberg AA N Engl J Med; 1993 Sep; 329(13):909-14. PubMed ID: 8361504 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617 [TBL] [Abstract][Full Text] [Related]
12. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Rubnitz JE; Morrissey J; Savage PA; Cleary ML Blood; 1994 Sep; 84(6):1747-52. PubMed ID: 8080983 [TBL] [Abstract][Full Text] [Related]
13. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner. Rogaia D; Grignani F; Carbone R; Riganelli D; LoCoco F; Nakamura T; Croce CM; Di Fiore PP; Pelicci PG Cancer Res; 1997 Mar; 57(5):799-802. PubMed ID: 9041173 [TBL] [Abstract][Full Text] [Related]
14. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Rubnitz JE; Link MP; Shuster JJ; Carroll AJ; Hakami N; Frankel LS; Pullen DJ; Cleary ML Blood; 1994 Jul; 84(2):570-3. PubMed ID: 8025282 [TBL] [Abstract][Full Text] [Related]
15. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cimino G; Rapanotti MC; Biondi A; Elia L; Lo Coco F; Price C; Rossi V; Rivolta A; Canaani E; Croce CM; Mandelli F; Greaves M Cancer Res; 1997 Jul; 57(14):2879-83. PubMed ID: 9230194 [TBL] [Abstract][Full Text] [Related]
16. Rearrangements involving chromosome band 11Q23 in acute leukaemia. Rowley JD Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623 [TBL] [Abstract][Full Text] [Related]
17. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes. Cortes J; O'Brien S; Kantarjian H; Cork A; Stass S; Freireich EJ; Keating M; Pierce S; Estey E Leukemia; 1994 Dec; 8(12):2174-8. PubMed ID: 7808007 [TBL] [Abstract][Full Text] [Related]
18. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Rowley JD; Diaz MO; Espinosa R; Patel YD; van Melle E; Ziemin S; Taillon-Miller P; Lichter P; Evans GA; Kersey JH Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9358-62. PubMed ID: 2251277 [TBL] [Abstract][Full Text] [Related]
19. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs]. Dassonneville L; Bailly C Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316 [TBL] [Abstract][Full Text] [Related]